Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin versus Mirena for endometrial hyperplasia
PACTR201908498370196Completed
- Sponsor
- Faculty of Medicine, Suez Canal University
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of avatrombopag and metformin in endometrial hyperplasia (EH) (2 arms), sponsored by Faculty of Medicine, Suez Canal University. Primary endpoint: Resolution of endometrial hyperplasia. Started Aug 2019; status: completed.
02
Drugs
avatrombopagmetformin
03
Conditions
endometrial hyperplasia (EH)
Beyond the preview
Go deeper on PACTR201908498370196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201908498370196.